The stock's fall snapped a two-day winning streak.

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

the pacemakers might enter safety mode under certain conditions, and as a result may not properly regulate the heart’s rhythm and rate, according to the FDA. Boston Scientific sent its clinician ...

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced ... At present, Boston owns 10 percent stake at SoniVie. Under the deal, the company would acquire the remaining stake in SoniVie ...

"Boston Scientific bags CE marking for Farapulse catheter and software" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has ...

Boston Scientific stock (NYSE: BSX) has gained 3% in the five days since its Q4 earnings report last week. Although the company exceeded expectations with both its results and guidance ...

and Boston Scientific Corp. (BSX), as well as micro-cap stock Cooper-Standard Holdings Inc. (CPS). The Zacks microcap research is unique as our research content on these small and under-the-radar ...

Shares of Boston Scientific Corp. BSX slid 5.04% to $94.13 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614.56 ...